Antiplatelet and anticoagulant agents in vitreoretinal surgery: A prospective multicenter study involving 804 patients

January 25, 2018

Antiplatelet and anticoagulant agents in vitreoretinal surgery: A prospective multicenter study involving 804 patients

Published on 01/24/2018

previous post: Botulinum toxin as a treatment for depression in a real-world setting
next post: Radiation exposure and attributable cancer risk in patients with esophageal atresia